簇集蛋白(CLU)單克隆抗體
Monoclonal Antibody to Clusterin (CLU)
CLU; TRPM2; KUB1; CLI; APOJ; SGP2; AAG4; APO-J; SP-40; Apolipoprotein J; Complement Lysis Inhibitor; 40,Sulfated Glycoprotein 2; Testosterone-Repressed Prostate Message 2
- 編號MAB180Po29
- 物種Sus scrofa; Porcine (Pig,豬) 相同的名稱,不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)D22
- Ig亞型 IgG1 Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 免疫原 RPB180Po01-簇集蛋白(CLU)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度1mg/ml
- 且適物種-
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術,請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 774 ¥ 1806 ¥ 2580 ¥ 6450 ¥ 25800
- 欲了解實際交易價格和更多情況,請與當地經銷商聯系!
特異性
該抗體是針對CLU的小鼠單克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別CLU。
用法
Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當的條件下存儲,損失率低于5%。
贈品
增值服務
相關產品
編號 | 適用物種:Sus scrofa; Porcine (Pig,豬) | 應用(僅供研究使用,不用于臨床診斷!) |
RPB180Po01 | 簇集蛋白(CLU)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB180Po01 | 簇集蛋白(CLU)多克隆抗體 | WB; IHC; ICC; IP. |
LAB180Po71 | 簇集蛋白(CLU)多克隆抗體(生物素標記) | WB; IHC; ICC. |
MAB180Po21 | 簇集蛋白(CLU)單克隆抗體 | WB,IHC |
MAB180Po22 | 簇集蛋白(CLU)單克隆抗體 | WB; IHC. |
MAB180Po23 | 簇集蛋白(CLU)單克隆抗體 | WB; IHC; ICC; IP. |
MAB180Po24 | 簇集蛋白(CLU)單克隆抗體 | WB; IHC; ICC; IP. |
MAB180Po25 | 簇集蛋白(CLU)單克隆抗體 | WB; IHC; ICC; IP. |
MAB180Po27 | 簇集蛋白(CLU)單克隆抗體 | WB; IHC; ICC; IP. |
MAB180Po29 | 簇集蛋白(CLU)單克隆抗體 | WB; IHC; ICC; IP. |
FAB180Po02 | 抗簇集蛋白(CLU)單克隆抗體 | Flow cytometry. |
SEB180Po | 簇集蛋白(CLU)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB180Po | 簇集蛋白(CLU)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSB180Po01 | 簇集蛋白(CLU)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
Endocrinology | Deficiency of Clusterin Exacerbates High-Fat Diet-Induced Insulin Resistance in Male Mice [Pubmed: 24684302] |
J Mol Neurosci. | Time-Dependent Decrease of Clusterin as a Potential Cerebrospinal Fluid Biomarker for Drug-Resistant Epilepsy. [Pubmed: 24488574] |
PLOS ONE | Serum Amyloid A and Clusterin as Potential Predictive Biomarkers for Severe Hand, Foot and Mouth Disease by 2D-DIGE Proteomics Analysis [Pubmed:25268271] |
journal of immunological methods | Proteomic analysis of human plasma and peripheral blood mononuclear cells in Systemic Lupus Erythematosus patients. [pubmed:28390925] |
Journal?of?Alzheimer's?Disease | Proteomics?Analysis?of?Blood?Serums?from?Alzheimer's?Disease?Patients?Using?iTRAQ?LabelingTechnology. [pubmed:27911324] |
Biochimica Et Biophysica Acta | Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells [pubmed:28941799] |
World Neurosurgery | Clusterin, a New Cerebrospinal Fluid Biomarker in Severe Subarachnoid Hemorrhage: A Pilot Study [pubmed:28803177] |
BMC Cancer | Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis [Pubmed:29386009] |
Diabetes/metabolism research and reviews | High serum clusterin levels are correlated with premature coronary artery disease in a Chinese population [Pubmed: 30659732] |
Cancer Cell Int | Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer [33602229] |
留言咨詢